GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $30.5B | +5.5% | 3.6% | −1.0% |
| Revenue (TTM) | $30.5B |
|---|---|
| YoY | +5.5% |
| 5-year CAGR | 3.6% |
| 10-year CAGR | −1.0% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $29.4B | +2.4% |
| 2024 | $28.8B | +6.0% |
| 2023 | $27.1B | −0.6% |
| 2022 | $27.3B | −0.1% |
| 2021 | $27.3B | +10.6% |
| 2020 | $24.7B | +10.0% |
| 2019 | $22.4B | +1.5% |
| 2018 | $22.1B | −15.2% |
| 2017 | $26.1B | −14.1% |
| 2016 | $30.4B | −6.9% |
| 2015 | $32.6B | +31.1% |
| 2014 | $24.9B | +122.2% |
| 2013 | $11.2B | +15.5% |
| 2012 | $9.7B | +15.7% |
| 2011 | $8.4B | +5.5% |
| 2010 | $7.9B | +13.4% |
| 2009 | $7.0B | +31.4% |
| 2008 | $5.3B | +26.1% |
| 2007 | $4.2B | — |